Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -543.56%-170.92M | ---- | 91.85%-26.56M | ---- | -167.01%-325.72M | ---- | 9.77%486.1M | ---- | -19.05%442.85M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 18.64%-30.45M | ---- | -0.62%-37.42M | ---- | -0.21%-37.19M | ---- | -95.28%-37.11M | ---- | -42.60%-19M |
| Interest expense - adjustment | ---- | -12.18%53.41M | ---- | -20.23%60.82M | ---- | -0.91%76.24M | ---- | 6.59%76.95M | ---- | -3.80%72.19M |
| Attributable subsidiary (profit) loss | ---- | -177.91%-4.49M | ---- | -44.12%5.76M | ---- | 461.93%10.32M | ---- | 91.85%-2.85M | ---- | -315.57%-34.95M |
| Impairment and provisions: | ---- | 41.43%28.43M | ---- | -89.48%20.1M | ---- | 56.53%191.07M | ---- | 119.29%122.07M | ---- | 130.82%55.67M |
| -Impairmen of inventory (reversal) | ---- | -91.00%1.37M | ---- | -6.07%15.17M | ---- | 4,277.24%16.15M | ---- | -63.54%369K | ---- | -22.15%1.01M |
| -Other impairments and provisions | ---- | 448.87%27.07M | ---- | -97.18%4.93M | ---- | 43.73%174.92M | ---- | 122.68%121.7M | ---- | 139.54%54.65M |
| Revaluation surplus: | ---- | 146.38%315.45M | ---- | 181.11%128.04M | ---- | -442.77%-157.86M | ---- | 1,348.27%46.06M | ---- | 102.52%3.18M |
| -Fair value of investment properties (increase) | ---- | 143.53%299.75M | ---- | 188.19%123.09M | ---- | -392.45%-139.57M | ---- | 3,605.28%47.72M | ---- | 101.15%1.29M |
| -Other fair value changes | ---- | 217.02%15.7M | ---- | 127.07%4.95M | ---- | -995.87%-18.29M | ---- | -188.21%-1.67M | ---- | 113.34%1.89M |
| Asset sale loss (gain): | ---- | -243.64%-576K | ---- | -62.73%401K | ---- | 120.28%1.08M | ---- | 90.05%-5.31M | ---- | -662.01%-53.35M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 90.22%-5.29M | ---- | -292.84%-54.08M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -243.64%-576K | ---- | -62.73%401K | ---- | 6,429.41%1.08M | ---- | -102.34%-17K | ---- | -89.25%727K |
| Depreciation and amortization: | ---- | -5.21%252.01M | ---- | -7.38%265.85M | ---- | 17.99%287.02M | ---- | 26.67%243.26M | ---- | 1.92%192.05M |
| -Depreciation | ---- | -5.29%211.11M | ---- | -9.16%222.91M | ---- | 21.58%245.37M | ---- | 29.43%201.82M | ---- | 1.36%155.93M |
| Special items | ---- | --13.71M | ---- | ---- | ---- | 384.18%570.81M | ---- | -1,043.40%-200.86M | ---- | ---17.57M |
| Operating profit before the change of operating capital | ---- | 9.49%456.58M | ---- | -32.28%416.99M | ---- | -15.45%615.77M | ---- | 13.61%728.31M | ---- | -5.71%641.06M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -483.89%-115.01M | ---- | -80.80%29.96M | ---- | 162.14%156.03M | ---- | -245.86%-251.09M | ---- | -1,414.69%-72.6M |
| Accounts receivable (increase)decrease | ---- | -325.91%-218.89M | ---- | -134.11%-51.39M | ---- | 148.71%150.65M | ---- | -150.00%-309.27M | ---- | -120.39%-123.71M |
| Accounts payable increase (decrease) | ---- | 213.16%125.81M | ---- | -72.88%-111.17M | ---- | -207.90%-64.31M | ---- | -51.17%59.6M | ---- | -54.68%122.04M |
| Special items for working capital changes | ---- | 774.05%19.03M | ---- | 111.14%2.18M | ---- | -162.99%-19.54M | ---- | 1,760.77%31.02M | ---- | 102.18%1.67M |
| Cash from business operations | ---- | -6.65%267.52M | ---- | -65.83%286.57M | ---- | 224.34%838.61M | ---- | -54.52%258.56M | ---- | -29.98%568.46M |
| Hong Kong profits tax paid | ---- | 96.74%-387K | ---- | -30.84%-11.87M | ---- | -319.95%-9.08M | ---- | -54.39%4.13M | ---- | --9.05M |
| China income tax paid | ---- | 35.71%-19.6M | ---- | 60.34%-30.49M | ---- | -2.20%-76.87M | ---- | -34.90%-75.21M | ---- | -35.91%-55.75M |
| Special items of business | 115.78%297.8M | ---- | -8.58%138.01M | ---- | -41.78%150.96M | ---- | 115.34%259.29M | ---- | -6.70%120.41M | ---- |
| Net cash from operations | 115.78%297.8M | 1.36%247.53M | -8.58%138.01M | -67.55%244.21M | -41.78%150.96M | 301.48%752.67M | 115.34%259.29M | -64.07%187.48M | -6.70%120.41M | -32.31%521.75M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -18.64%30.45M | ---- | 0.62%37.42M | ---- | 0.21%37.19M | ---- | 90.08%37.11M | ---- | 49.75%19.52M |
| Dividend received - investment | ---- | ---- | ---- | -6.19%3.26M | -7.36%3.35M | --3.47M | --3.61M | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | -88.30%3.88M | ---- | 370.82%33.19M | ---- | -5,792.31%-12.26M | ---- | ---208K | ---- | ---- |
| Decrease in deposits (increase) | 136.42%48.37M | -195.85%-162.33M | -275.95%-132.8M | -26.92%169.37M | -116.38%-35.32M | 156.96%231.76M | 165.74%215.71M | -268.16%-406.85M | -303.14%-328.12M | 20.48%-110.51M |
| Sale of fixed assets | -10.85%978K | 147.27%4.45M | -60.35%1.1M | -23.39%1.8M | 69.44%2.77M | 161.94%2.35M | -75.59%1.63M | 125.13%896K | 802.70%6.69M | -22.42%398K |
| Purchase of fixed assets | -48.76%-490.68M | -28.02%-527.41M | -57.87%-329.85M | -36.66%-411.96M | -32.85%-208.94M | 30.16%-301.44M | 48.58%-157.28M | -86.55%-431.64M | -179.20%-305.9M | -104.90%-231.38M |
| Purchase of intangible assets | ---- | -21.37%-25.1M | -3,037.02%-21.27M | 64.71%-20.68M | 75.06%-678K | -341.44%-58.61M | 51.28%-2.72M | 77.62%-13.28M | 15.30%-5.58M | 17.24%-59.31M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --39.6M |
| Recovery of cash from investments | --16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3,660.64%595.95M |
| Cash on investment | ---- | -339.54%-86.79M | ---- | 86.20%-19.75M | ---- | -340.93%-143.04M | ---- | 50.57%-32.44M | ---- | -2,869.46%-65.63M |
| Other items in the investment business | -18.47%12.07M | --74M | -52.30%14.81M | ---- | 64.86%31.05M | ---- | -94.85%18.83M | 1,936.34%366.71M | 672.76%365.51M | --18.01M |
| Net cash from investment operations | 11.70%-413.27M | -232.21%-688.85M | -125.24%-468.02M | 13.81%-207.36M | -360.43%-207.78M | 49.85%-240.58M | 129.84%79.79M | -332.13%-479.7M | -78.86%-267.4M | 169.72%206.65M |
| Net cash before financing | 65.01%-115.47M | -1,297.63%-441.33M | -480.78%-330M | -92.80%36.85M | -116.76%-56.82M | 275.23%512.09M | 330.67%339.07M | -140.12%-292.23M | -618.74%-147M | 53.54%728.4M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 481.23%158.46M | -52.94%260.29M | -95.21%27.26M | --553.1M | --569.62M | ---- | ---- | ---- | ---- | ---- |
| Refund | -77.42%-78.55M | 84.89%-86.34M | 92.36%-44.28M | -4,745.23%-571.35M | -4,175.05%-579.61M | 1.30%-11.79M | ---13.56M | -50.35%-11.95M | ---- | ---7.95M |
| Interest paid - financing | 34.63%-16.92M | 18.32%-49.53M | 15.94%-25.88M | 20.48%-60.64M | 6.97%-30.79M | 0.89%-76.26M | ---33.09M | -6.59%-76.95M | ---- | 3.80%-72.19M |
| Dividends paid - financing | ---- | ---- | ---- | 35.70%-61.67M | ---- | -12.14%-95.92M | 17.35%-19.63M | -2.05%-85.54M | ---23.75M | -69.34%-83.83M |
| Other items of the financing business | ---- | ---- | 14.80%6.52M | 36.79%12.15M | 339.03%5.68M | -32.69%8.89M | 103.43%1.29M | --13.2M | -5.63%-37.76M | ---- |
| Net cash from financing operations | 180.31%43.83M | 155.18%92.02M | 0.36%-54.57M | 20.45%-166.77M | 31.37%-54.77M | -8.35%-209.64M | -4.21%-79.81M | -0.36%-193.49M | -53.33%-76.58M | -30.97%-192.79M |
| Effect of rate | 493.88%37.5M | 46.65%-5.29M | 79.29%-9.52M | 79.59%-9.92M | -2.63%-45.98M | -374.27%-48.6M | -500.49%-44.8M | -68.35%17.72M | 19.93%11.19M | 492.28%55.97M |
| Net Cash | 81.37%-71.64M | -168.85%-349.31M | -244.63%-384.57M | -142.96%-129.92M | -143.04%-111.59M | 162.27%302.44M | 215.96%259.27M | -190.69%-485.72M | -217.59%-223.58M | 63.70%535.61M |
| Begining period cash | -23.50%1.15B | -8.48%1.51B | -8.48%1.51B | 18.20%1.65B | 18.20%1.65B | -25.12%1.4B | -25.12%1.4B | 46.52%1.86B | 46.52%1.86B | 32.64%1.27B |
| Cash at the end | 0.48%1.12B | -23.50%1.15B | -25.24%1.12B | -8.48%1.51B | -7.34%1.49B | 18.20%1.65B | -2.49%1.61B | -25.12%1.4B | 36.37%1.65B | 46.52%1.86B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.